Corbus Pharmaceuticals I... (CRBP)
12.25
0.80 (6.99%)
At close: Jan 15, 2025, 10:28 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | 881.71K | 3.94M | 36.14M | 4.82M | 2.44M | 1.91M | 648.38K | n/a | n/a | n/a |
| Cost of Revenue | 31.17M | 1.49M | 1.64M | 98.27K | 89.60K | 48.61M | 26.04M | 15.44M | 5.89M | 1.26M | n/a | n/a |
| Gross Profit | -31.17M | -1.49M | -757.53K | 3.84M | 36.05M | -43.79M | -23.60M | -13.53M | -5.24M | -1.26M | n/a | n/a |
| Operating Income | -45.08M | -39.84M | -55.99M | -122.81M | -77.10M | -56.75M | -32.56M | -19.99M | -8.85M | -2.65M | -557.28K | -824.15 |
| Interest Income | n/a | n/a | 1.83K | 1.03K | 1.23M | 982.78K | 183.11K | 477.00 | 3.42K | 2.12K | 754.00 | 59.74 |
| Pretax Income | -44.60M | -42.35M | -45.64M | -111.27M | -71.45M | -55.67M | -32.42M | -20.00M | -8.85M | -2.54M | -602.35K | -886.96 |
| Net Income | -44.60M | -55.83M | -45.55M | -111.30M | -69.15M | -55.67M | -32.42M | -20.00M | -8.85M | -2.54M | -602.35K | -886.96 |
| Selling & General & Admin | 13.27M | 18.70M | 20.43M | 28.48M | 23.64M | 12.96M | 8.96M | 6.46M | 3.61M | 1.39M | 346.61K | 289.05 |
| Research & Development | 31.17M | 16.14M | 36.45M | 98.27M | 89.60M | 48.61M | 26.04M | 15.44M | 5.89M | 1.26M | 210.67K | 575.09 |
| Other Expenses | -30.53M | -48.77K | 11.90M | 13.27M | 4.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 13.91M | 34.84M | 56.87M | 126.75M | 113.25M | 61.57M | 35.00M | 21.90M | 9.50M | 2.65M | 557.28K | 827.22 |
| Interest Expense | 2.92M | 2.13M | 1.83M | 1.03M | 19.02K | n/a | 183.11K | n/a | 2.44K | 24.02K | 45.11K | n/a |
| Selling & Marketing Expenses | -641.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 45.08M | 34.84M | 56.87M | 126.75M | 113.25M | 61.57M | 35.00M | 21.90M | 9.50M | 2.65M | 557.28K | 827.22 |
| Income Tax | n/a | 13.49M | -87.84K | 35.05K | -2.30M | 1.08M | -396.86K | 13.62K | 2.44K | 24.02K | 44.36K | -62.81 |
| Shares Outstanding (Basic) | 4.33M | 4.17M | 4.10M | 2.60M | 2.13M | 1.90M | 1.67M | 1.37M | 1.05M | 672.00K | 860.06K | 232.00 |
| Shares Outstanding (Diluted) | 4.33M | 4.17M | 4.10M | 2.60M | 2.13M | 1.90M | 1.67M | 1.37M | 1.05M | 672.00K | 860.06K | 232.16 |
| EPS (Basic) | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.3 | -19.38 | -14.58 | -8.47 | -3.78 | -0.7 | -3.82 |
| EPS (Diluted) | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.3 | -19.38 | -14.58 | -8.47 | -3.78 | -0.7 | -3.82 |
| EBITDA | -44.44M | -38.73M | -54.97M | -121.69M | -76.37M | -56.25M | -32.31M | -19.90M | -8.81M | -2.64M | -556.52K | -62.81 |
| Depreciation & Amortization | 641.00K | 1.49M | 1.64M | 1.69M | 1.23M | 493.94K | 255.65K | 87.66K | 43.94K | 10.40K | 754.00 | 824.15 |